Correction to: HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation

Detalles Bibliográficos
Autores principales: Roca, Maria Serena, Moccia, Tania, Iannelli, Federica, Testa, Cristina, Vitagliano, Carlo, Minopoli, Michele, Camerlingo, Rosa, De Riso, Giulia, De Cecio, Rossella, Bruzzese, Francesca, Conte, Mariarosaria, Altucci, Lucia, Di Gennaro, Elena, Avallone, Antonio, Leone, Alessandra, Budillon, Alfredo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9004159/
https://www.ncbi.nlm.nih.gov/pubmed/35410264
http://dx.doi.org/10.1186/s13046-022-02324-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9004159/
https://www.ncbi.nlm.nih.gov/pubmed/35410264
http://dx.doi.org/10.1186/s13046-022-02324-2

Ejemplares similares